100 related articles for article (PubMed ID: 10374339)
1. [Study on p53 protein expression, cell proliferation and apoptosis in benign and malignant brain tumors].
Yu S; Pu P; Jiang D
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):293-6. PubMed ID: 10374339
[TBL] [Abstract][Full Text] [Related]
2. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
Yu S; Pu P; Jiang D; An T; Guan X; Yang L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of PCNA, Ki67, AgNOR and p53 expression in brain glial tumors].
Berny W; Weiser A; Markowska-Woyciechowska A; Jarmundowicz W; Zub W; Załuski R
Neurol Neurochir Pol; 2004; 38(6):457-63. PubMed ID: 15654669
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
Korshunov AG; Sycheva RV
Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
[TBL] [Abstract][Full Text] [Related]
6. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
[TBL] [Abstract][Full Text] [Related]
8. Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway.
Zhang LY; Ye J; Zhang F; Li FF; Li H; Gu Y; Liu F; Chen GS; Li Q
Int J Oncol; 2009 Jul; 35(1):25-32. PubMed ID: 19513548
[TBL] [Abstract][Full Text] [Related]
9. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
Bian XW; Shi JQ; Liu FX
Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
[TBL] [Abstract][Full Text] [Related]
10. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
Suren D; Isiksacan Ozen O
J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers relating to malignant progression in Grade II astrocytoma.
Yue WY; Yu SH; Zhao SG; Chen ZP
J Neurosurg; 2009 Apr; 110(4):709-14. PubMed ID: 19025355
[TBL] [Abstract][Full Text] [Related]
12. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
Momota H; Narita Y; Matsushita Y; Miyakita Y; Shibui S
Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 in glioblastoma multiforme cells: relationship to survival, proliferation and glycosylation.
Ehrmann J; Kolár Z; Kala M; Vojtĕsek B; Komenda S
Cesk Patol; 1995 Aug; 31(3):87-91. PubMed ID: 9444787
[TBL] [Abstract][Full Text] [Related]
14. Prognostic analysis of astrocytic gliomas correlating histological parameters with the proliferating cell nuclear antigen labelling index (PCNA-LI).
Cruz-Sánchez FF; Ferreres JC; Figols J; Palacin A; Cardesa A; Rossi ML; Val-Bernal JF
Histol Histopathol; 1997 Jan; 12(1):43-9. PubMed ID: 9046042
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
16. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
17. [An immunohistochemical study of the expression of the oncoprotein p53 in astrocytic gliomas of the cerebral hemispheres].
Korshunov AG; Sycheva RV
Arkh Patol; 1996; 58(6):37-42. PubMed ID: 9139592
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma.
Malhan P; Husain N; Bhalla S; Gupta RK; Husain M
Indian J Pathol Microbiol; 2010; 53(1):20-3. PubMed ID: 20090216
[TBL] [Abstract][Full Text] [Related]
19. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.
Cunningham JM; Kimmel DW; Scheithauer BW; O'Fallon JR; Novotny PJ; Jenkins RB
J Neurosurg; 1997 Jan; 86(1):121-30. PubMed ID: 8988090
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.
Eneström S; Vavruch L; Frånlund B; Nordenskjöld B
Neurochirurgie; 1998 Mar; 44(1):25-30. PubMed ID: 9757314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]